These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38218171)

  • 1. AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy.
    Sun T; Liu B; Cao Y; Li Y; Cai L; Yang W
    Cancer Lett; 2024 Feb; 583():216605. PubMed ID: 38218171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.
    Ma D; Liu S; Lal B; Wei S; Wang S; Zhan D; Zhang H; Lee RS; Gao P; Lopez-Bertoni H; Ying M; Li JJ; Laterra J; Wilson MA; Xia S
    Cancer Res; 2019 May; 79(10):2697-2708. PubMed ID: 30898840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment.
    Sakakura K; Takahashi H; Kaira K; Toyoda M; Murata T; Ohnishi H; Oyama T; Chikamatsu K
    Lab Invest; 2016 Sep; 96(9):994-1003. PubMed ID: 27322955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion.
    Jiang N; Xie B; Xiao W; Fan M; Xu S; Duan Y; Hamsafar Y; Evans AC; Huang J; Zhou W; Lin X; Ye N; Wanggou S; Chen W; Jing D; Fragoso RC; Dugger BN; Wilson PF; Coleman MA; Xia S; Li X; Sun LQ; Monjazeb AM; Wang A; Murphy WJ; Kung HJ; Lam KS; Chen HW; Li JJ
    Nat Commun; 2022 Mar; 13(1):1511. PubMed ID: 35314680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
    Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
    Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking CD47 promotes antitumour immunity through CD103
    Wang S; Wu Q; Chen T; Su R; Pan C; Qian J; Huang H; Yin S; Xie H; Zhou L; Zheng S
    J Hepatol; 2022 Aug; 77(2):467-478. PubMed ID: 35367532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
    Zhang M; Hutter G; Kahn SA; Azad TD; Gholamin S; Xu CY; Liu J; Achrol AS; Richard C; Sommerkamp P; Schoen MK; McCracken MN; Majeti R; Weissman I; Mitra SS; Cheshier SH
    PLoS One; 2016; 11(4):e0153550. PubMed ID: 27092773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.
    Wang LL; Wan XY; Wang TL; Liu CQ; Zheng FM
    Med Oncol; 2022 Oct; 39(12):254. PubMed ID: 36224405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells.
    Chang CL; Wu CC; Hsu YT; Hsu YC
    Oncoimmunology; 2020 Aug; 9(1):1803530. PubMed ID: 32923164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 11. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.
    Jaiswal S; Jamieson CH; Pang WW; Park CY; Chao MP; Majeti R; Traver D; van Rooijen N; Weissman IL
    Cell; 2009 Jul; 138(2):271-85. PubMed ID: 19632178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G9a promotes immune suppression by targeting the Fbxw7/Notch pathway in glioma stem cells.
    Cao Y; Liu B; Cai L; Li Y; Huang Y; Zhou Y; Sun X; Yang W; Sun T
    CNS Neurosci Ther; 2023 Sep; 29(9):2508-2521. PubMed ID: 36971192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.
    Zhang H; Lu H; Xiang L; Bullen JW; Zhang C; Samanta D; Gilkes DM; He J; Semenza GL
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):E6215-23. PubMed ID: 26512116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells.
    Candas-Green D; Xie B; Huang J; Fan M; Wang A; Menaa C; Zhang Y; Zhang L; Jing D; Azghadi S; Zhou W; Liu L; Jiang N; Li T; Gao T; Sweeney C; Shen R; Lin TY; Pan CX; Ozpiskin OM; Woloschak G; Grdina DJ; Vaughan AT; Wang JM; Xia S; Monjazeb AM; Murphy WJ; Sun LQ; Chen HW; Lam KS; Weichselbaum RR; Li JJ
    Nat Commun; 2020 Sep; 11(1):4591. PubMed ID: 32929084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of HER2 and CD47 CAR-macrophage in ovarian cancer.
    Chen Y; Zhu X; Liu H; Wang C; Chen Y; Wang H; Fang Y; Wu X; Xu Y; Li C; Lv X; Huang J; Han X; Li R; Hong W; Yu Z; Wei W; Tu J
    J Transl Med; 2023 Sep; 21(1):654. PubMed ID: 37740183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CD47 Inhibits Tumor Development and Increases Phagocytosis in Oral Squamous Cell Carcinoma.
    Ye XJ; Yang JG; Tan YQ; Chen XJ; Zhou G
    Anticancer Agents Med Chem; 2021; 21(6):766-774. PubMed ID: 32748759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12.
    Rodríguez MM; Fiore E; Bayo J; Atorrasagasti C; García M; Onorato A; Domínguez L; Malvicini M; Mazzolini G
    Mol Ther; 2018 Dec; 26(12):2738-2750. PubMed ID: 30301668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
    Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y
    J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant Isocitrate Dehydrogenase 1 Disrupts PKM2-β-Catenin-BRG1 Transcriptional Network-Driven CD47 Expression.
    Gowda P; Patrick S; Singh A; Sheikh T; Sen E
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.